Aridis Pharmaceuticals, Inc.
ARDSDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted in 2025; its insiders filed their last Form 4 on Jun 28, 2024; 1 institution reported holding it in 13F filings for Q3 2025, worth $3 in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in Aridis Pharmaceuticals, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ARDS is no longer listed, so this page shows Q3 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 1
- +1 vs. Q2 2025
- Shares held
- 3.00K
- +3.00K vs. Q2 2025
- Total value
- $3
- +$3 vs. Q2 2025
- New holders
- 1
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARDS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $1 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $3 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $10 |
| Q3 2023 | 1 | $1.44K |
| Q2 2023 | 18 | $392.3K |
| Q1 2023 | 20 | $1.29M |
| Q4 2022 | 17 | $4.58M |
| Q3 2022 | 16 | $1.79M |
| Q2 2022 | 19 | $2.05M |
| Q1 2022 | 22 | $3.38M |
| Q4 2021 | 20 | $3.08M |
| Q3 2021 | 18 | $7.33M |
| Q2 2021 | 13 | $7.87M |
| Q1 2021 | 12 | $5.97M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Aridis Pharmaceuticals, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Strengthening Families & Communities, LLC | 3,000 | $3 | 0.00% | +3,000 | New |